Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eledon Pharmaceuticals (ELDN) Depreciation and Depletion (2016 - 2017)

Historic Depreciation and Depletion for Eledon Pharmaceuticals (ELDN) over the last 5 years, with Q1 2017 value amounting to $17000.0.

  • Eledon Pharmaceuticals' Depreciation and Depletion fell 6792.45% to $17000.0 in Q1 2017 from the same period last year, while for Mar 2017 it was $135000.0, marking a year-over-year decrease of 1401.27%. This contributed to the annual value of $171000.0 for FY2016, which is 5688.07% up from last year.
  • According to the latest figures from Q1 2017, Eledon Pharmaceuticals' Depreciation and Depletion is $17000.0, which was down 6792.45% from $17000.0 recorded in Q4 2016.
  • Eledon Pharmaceuticals' 5-year Depreciation and Depletion high stood at $56000.0 for Q4 2015, and its period low was $3000.0 during Q4 2013.
  • Moreover, its 5-year median value for Depreciation and Depletion was $16500.0 (2015), whereas its average is $22928.6.
  • In the last 5 years, Eledon Pharmaceuticals' Depreciation and Depletion soared by 102000.0% in 2015 and then tumbled by 6964.29% in 2016.
  • Over the past 5 years, Eledon Pharmaceuticals' Depreciation and Depletion (Quarter) stood at $3000.0 in 2013, then soared by 66.67% to $5000.0 in 2014, then surged by 1020.0% to $56000.0 in 2015, then crashed by 69.64% to $17000.0 in 2016, then changed by 0.0% to $17000.0 in 2017.
  • Its Depreciation and Depletion stands at $17000.0 for Q1 2017, versus $17000.0 for Q4 2016 and $49000.0 for Q3 2016.